Condition: Cerebral Toxoplasmosis · Sponsor: University Hospital, Strasbourg, France
Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prevention).
This description comes directly from the study's public registry record.
Mathilde HERBER, MD · 33 3.69.55.13.99 · mathilde.herber@chru-strasbourg.fr
Always discuss trial participation with your own doctor first.
| Service d'immunologie clinique - Hôpitaux Universitaires de Strasbourg | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07299500